Microbix Biosystems Inc.

TSX:MBX Rapporto sulle azioni

Cap. di mercato: CA$42.0m

Microbix Biosystems Performance dei guadagni passati

Il passato criteri di controllo 2/6

Microbix Biosystems ha registrato una crescita degli utili a un tasso medio annuo di 48.5%, mentre il settore Biotechs ha registrato utili in crescita a un tasso medio annuo di 19.3%. I ricavi sono stati in crescita a un tasso medio annuo di 13%. Il ritorno sul capitale proprio di Microbix Biosystems è 18.1% e ha margini netti di 21.7%.

Informazioni chiave

48.5%

Tasso di crescita degli utili

49.6%

Tasso di crescita dell'EPS

Biotechs Crescita del settore51.1%
Tasso di crescita dei ricavi13.0%
Rendimento del capitale proprio18.1%
Margine netto21.7%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Recent updates

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Dec 23
Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Nov 03
Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Jul 22
Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

May 17
Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Dec 27
Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Aug 08
Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20
Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

Feb 06
Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Dec 28
One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Oct 14
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 15
Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

May 17
A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Mar 24
Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

Jan 29
We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

Ripartizione dei ricavi e delle spese

Come Microbix Biosystems guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

TSX:MBX Ricavi, spese e utili (CAD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 2423592
31 Mar 24244102
31 Dec 2322492
30 Sep 2317082
30 Jun 2317-382
31 Mar 2316-172
31 Dec 2217072
30 Sep 2219272
30 Jun 2220362
31 Mar 2221462
31 Dec 2120461
30 Sep 2119351
30 Jun 2116-351
31 Mar 2113-451
31 Dec 2012-641
30 Sep 2011-641
30 Jun 2011-141
31 Mar 2012-141
31 Dec 1913051
30 Sep 1913041
30 Jun 1913-841
31 Mar 1913-841
31 Dec 1812-941
30 Sep 1813-941
30 Jun 1812-141
31 Mar 1811-151
31 Dec 1711-141
30 Sep 1710-441
30 Jun 1711-241
31 Mar 1710-241
31 Dec 1610-241
30 Sep 1610140
30 Jun 168031
31 Mar 168031
31 Dec 158031
30 Sep 159131
30 Jun 159041
31 Mar 159031
31 Dec 148031
30 Sep 148031
30 Jun 149120
31 Mar 148130
31 Dec 139130

Guadagni di qualità: MBX ha un livello elevato di guadagni non monetari.

Margine di profitto in crescita: MBX è diventata redditizia in passato.


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: MBX è diventata redditizia negli ultimi 5 anni, aumentando i guadagni del 48.5% all'anno.

Accelerare la crescita: MBX è diventata redditizia nell'ultimo anno, rendendo difficile confrontare il tasso di crescita degli utili con la media quinquennale.

Guadagni vs Settore: MBX è diventata redditizia nell'ultimo anno, rendendo difficile confrontare la crescita dei suoi utili dell'anno passato con il settore Biotechs ( 16.6% ).


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 18.1% ) di MBX è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate